DMRA smart money
Damora Therapeutics, INC. (DMRA): 1 insider buy, 10 top funds holding it, 1 ETF change in the public filings.
Insider buys, 12 months$253k
Insider buys
| Filed | Who | Role | Amount | Price |
|---|---|---|---|---|
| 2026-09-28 | Jarrett Jennifer | Director, President and CEO | $253k | $20.23 |
Top 100 funds holding it
| # | Fund | Change | Weight | Value |
|---|---|---|---|---|
| 2 | Venrock Adviser, LLC | BUY | 3.73% | $77M |
| 3 | Fairmount Funds Management LLC | BUY | 11.63% | $185M |
| 22 | Braidwell LP | BUY | 1.60% | $37M |
| 31 | Affinity Asset Advisors, LLC | BUY | 0.46% | $8M |
| 46 | Sofinnova Investments, INC. | BUY | 0.16% | $3M |
| 50 | Siren, L.L.C. | BUY | 0.45% | $19M |
| 63 | Vestal Point Capital, LP | BUY | 0.22% | $8M |
| 80 | Avoro Capital Advisors LLC | BUY | 0.83% | $80M |
| 86 | Adar1 Capital Management, LLC | BUY | 0.28% | $6M |
| 96 | Pfm Health Sciences, LP | BUY | 0.33% | $3M |
ETF changes
| ETF | Change | Value | Report |
|---|---|---|---|
| State Street(R) Spdr(R) S&p(R) Biotech ETF | ADD | +$16M | 2026-06-30 |